Search

AF solution

Chevron
Service Type
Arrow Hook

Oncology

Chevron

All

Vector 4

Small Molecule

Antibody

Cancer Vaccine​

mRNA

Immune Cell​

TME – CAF

Zebrafish Drug Test

Immuno Oncology

Chevron

All

Vector 4

Macrophage

Regulatory T Cell

Tumor-Infiltrating Lymphocyte

Cytotoxic T Cell

Anti-Virus

Chevron

All

Vector 4

Coronavirus

Influenza Virus

HPV

Adenovirus

Disease Modeling

Chevron

All

Vector 4

GI Tract Disease Model

Gland Disease Model

Metabolic Disease Model

Brain & CNS Disease Model

Respiratory and ENT Disease

Cosmetics

Chevron

All

Vector 4

Brightening

Anti-Aging

Anti-Inflammation

Anti-Oxidant

Anti-Hair Loss

Hair Growth

Skin Irritation

Skin Barrier

Microbiome

Chevron

All

Vector 4

Probiotic Adhesion Assay (2D)

Host-Microbiome Study (3D)

Toxicity

Chevron

All

Vector 4

Organoid Based

OECD

Chevron

All

Vector 4

Eye Irritation

Skin Irritation

Phototoxicity Test

Skin Corrosion

Spatial Biology

Chevron

All

Vector 4

Protein Solution

RNA Solution

Technology Service

Chevron

All

Vector 4

CRISPR-Cas9

iPSC Generation

Viral Vector Cloning

Next-Generation Sequencing (NGS)

scRNA Sequence

Resource Type
Arrow Hook
Normal Organoid
Chevron

All

Vector 4

Intestinal Organoid

Skin & Hair Folicle Organoid

Kidney Organoid​

Cardiac Organoid

Salivary Gland Organoid​

Lacrimal Gland Organoid

Tonsil Organoid

Adenoid Organoid

Retinal Organoid

Lung Organoid

Cerebral Organoid

Midbrain Organoid

Liver Organoid

Cancer Organoid

Chevron

All

Vector 4

Colorectal Cancer

Non-Small Cell Lung Cancer

Pancreatic Cancer

Breast Cancer

Cholangiocarcinoma

Gastric Cancer

Ovarian Cancer

Hepatocarcinoma Cancer

Endometrial Cancer

Immune Cell

Chevron

All

Vector 4

Macrophage

Regulatory T Cell

Tumor-Infiltrating Lymphocyte

Cytotoxic T Cell

2D Cell

Chevron

All

Vector 4

Cancer Associate Fibroblast (CAF)

BALB 3T3

Melanocyte

MNT-1

B16F10

Melan-A

Spatial Biology

Chevron

All

Vector 4

CODEX

OPAL

Visium

GeoMX

Research Service

Chevron

All

Vector 4

CRISPR-Cas9

iPSC Generation

Viral Vector Cloning

Next-Generation Sequencing (NGS)

scRNA Sequence

Others

Chevron

All

Vector 4

Zebrafish

Egg

Cornea

Artificial Skin

Introduction

Arrow Hook

Event

Arrow Hook

Resources

BioArt

About

Get Started
Login
B16F10_main
2D Cell

B16F10

B16F10_main

  • Pigmentation Insight
▶ Utilize the B16F1 cell line to gain valuable insights into melanin production mechanisms, essential for developing effective skin brightening treatments.
  • Efficacy Testing
▶ Leverage B16F1 cells to test and validate the effectiveness of brightening agents, ensuring they effectively reduce pigmentation and enhance skin luminosity.
  • Safety and Toxicity Assessments
▶ Employ B16F1 cells to conduct thorough safety and toxicity evaluations of new skin care products, guaranteeing they are safe for consumer use while achieving desired brightening effects.
Organism
Product Type
Tissue
Disease

Applications

In vitro 3T3 NR (OECD TG 432)

Comparison of cytotoxicityinduced by chemicals under exposure to non-cytotoxic levels of light versus no exposure to light.

Ask a Question
Request a Quote
Table of Contents
Ask a Question
Request a Quote

Skin brightening

The skin brightening efficacy test is a thorough evaluation process designed to measure the effectiveness of skincare products in enhancing skin radiance.
It involves baseline assessments, consistent product application, and data collection using advanced analysis tools.

Assay process

  • Step 1_1: After culturing the cell line, it undergoes a stabilization process.
  • Step 1_2: Identify the concentration range for sample toxicity and establish the test concentration.
  • Step 2_1: Stabilize the cells by culturing them in a 48-well plate for approximately 1 day.
  • Step 2_2: After verifying the condition of the stabilized cells, treat them with the melanin production-stimulating hormone (a-MSH), either alone or simultaneously with the sample.
  • Step 2_3: Assess the whitening efficacy by comparing the amount of melanin production in the group treated with a-MSH alone and the group treated simultaneously with the sample
  • Step 3_1: Confirmation through repeated experiments, spanning from the initial cell seeding to the formation of melanin.
  • Step 3_2: Arranging raw data and generating quantitative or morphology data.

Read Out

Cell viability (% Neutral red uptake of dark controls)
  1. Microscopy data (cell morphology)
  2. Extracellular melanin content (%) data
  3. Intracellualr melanin content (%) data
Stimulation
  1. General screening stimulus: a-MSH (B16 cell line)
  2. In a light-induced melanin production model, the stimulus source can be replaceable with UVB
  3. Efficacy screening is feasible without irritants when utilizing cell lines other than the B16 cell line (high reproducibility).
Cell line
  1. Murine melanoma cell line : B16F10 , Melan-A
  2. Human melanoma cell lin : MNT-1
  3. Primary human melanocytes

AF Solution

Resources

Lambda

BioArt

Lambda Biologics

Lambda Biologics

Contact

+49 (0) 152 293 76591

info@lambdabiologics.com​

Deutscher Pl. 5c

04103 Leipzig

Germany

@ 2024 . All rights reserved

Privacy Policy

Term of Services

Cookie Settings

Deutscher Pl. 5c

04103 Leipzig

Germany

@ 2024 . All rights reserved

Privacy Policy
Term of Services
Cookie Settings